Néboa Zozaya (N Zozaya, N Zozaya González)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

Orphanet journal of rare diseases

Applied health economics and health policy

BMC public health

International journal of environmental research and public health

Weber

Universidad Carlos III de Madrid (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Weber May 01 2013

Spain

Directora :: Econom´ía de la Salud

Education History

Universidad Carlos III de Madrid Sep 01 2002 - Jun 30 2004

Spain

MSC

Universidad Carlos III de Madrid Sep 01 1997 - Jun 30 2002

Spain

BSC

Publications

Aurora Ortiz Nunez, Judit Gonzalez Portela, Néboa Zozaya, Irene Fernández
Narrative review of value frameworks in urothelial carcinoma and positioning of enfortumab vedotin. Journal of medical economics (2024)
Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Maurício Francis Abdalla, Benito Cadenas-Noreña, Miguel Ángel Ma Calleja-Hernández, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrandiz, Juan Oliva, José Luis Trillo, Álvaro Hidalgo-Vega
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries. Applied health economics and health policy (2024)
Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Maurício Francis Abdalla, Benito Cadenas-Noreña, Miguel Ángel Ma Calleja-Hernández, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrandiz, Juan Oliva, José Luis Trillo, Álvaro Hidalgo-Vega
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries. Applied health economics and health policy 22 (3) (2024)
Néboa Zozaya, Javier Villaseca, Irene Fernández, Fernando Maurício Francis Abdalla, Benito Cadenas-Noreña, Miguel Ángel Ma Calleja-Hernández, Pedro Gómez-Pajuelo, Jorge Mestre-Ferrandiz, Juan Oliva, José Luis Trillo, Álvaro Hidalgo-Vega
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries. Applied health economics and health policy 22 (3) (2024)
Néboa Zozaya, J Villaseca, F Abdalla, A Ancochea, I Málaga, M Trapero-Bertran, N Martín-Sobrino, O Delgado, P Ferré, A Hidalgo-Vega
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper. Orphanet journal of rare diseases 18 (1) (2023)
Néboa Zozaya, J Villaseca, F Abdalla, A Ancochea, I Málaga, M Trapero-Bertran, N Martín-Sobrino, O Delgado, P Ferré, A Hidalgo-Vega
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper. Orphanet journal of rare diseases 18 (1) (2023)
Néboa Zozaya, J Villaseca, F Abdalla, A Ancochea, I Málaga, M Trapero-Bertran, N Martín-Sobrino, O Delgado, P Ferré, A Hidalgo-Vega
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper. Orphanet journal of rare diseases 18 (1) (2023)
Néboa Zozaya, J Villaseca, F Abdalla, A Ancochea, I Málaga, M Trapero-Bertran, N Martín-Sobrino, O Delgado, P Ferré, A Hidalgo-Vega
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper. Orphanet journal of rare diseases 18 (1) (2023)
Néboa Zozaya, J Villaseca, F Abdalla, A Ancochea, I Málaga, M Trapero-Bertran, N Martín-Sobrino, O Delgado, P Ferré, A Hidalgo-Vega
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper. Orphanet journal of rare diseases 18 (1) (2023)
Néboa Zozaya, J Villaseca, F Abdalla, A Ancochea, I Málaga, M Trapero-Bertran, N Martín-Sobrino, O Delgado, P Ferré, A Hidalgo-Vega
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper. Orphanet journal of rare diseases 18 (1) (2023)
Néboa Zozaya, Maria Iciar Arrizubieta Basterrechea, Elena Bollo, Iván Castellví, Jaime Espín, Norberto Ortego, José Luis Poveda-Andrés, José Antonio Rodríguez Portal, Agustín Rivero, José Antonio Marcos-Rodríguez, Luis Verde
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. International journal of technology assessment in health care 38 (1) (2022)
Néboa Zozaya, Fernando Abdalla, Santiago Alfonso Zamora, Jesús Balea Filgueiras, Y José Manuel Carrascosa, Olga Delgado Sánchez, Francisco Dolz Sinisterra, Antonio J Garcia-Ruiz, Pedro Herranz Pinto, Antonio Manfredi, José Martínez Olmos, Paloma Morales de Los Ríos Luna, Lluis L Puig, Sandra Ros, Álvaro HIdalgo-Vega
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis. Expert review of pharmacoeconomics & outcomes research 22 (6) (2022)
Néboa Zozaya, Juan Oliva, Laura Vallejo-Torres
Association between maternal and paternal employment and their children's weight status and unhealthy behaviours: does it matter who the working parent is? BMC public health 22 (1) (2022)
Néboa Zozaya, Javier Villaseca, Fernando Maurício Francis Abdalla, Miguel Ángel Ma Calleja-Hernández, José Luis Díez-Martín, J Estévez, Miriam Santero, Joaquin Martinez Lopez, J Sierra, Ruth Vera, Álvaro Hidalgo-Vega
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (6) (2022)
Néboa Zozaya, Laura Vallejo
The Effect of the Economic Crisis on Adolescents' Perceived Health and Risk Behaviors: A Multilevel Analysis. International journal of environmental research and public health 17 (2) (2020)
Néboa Zozaya, Bleric Alcalá, P Arrazola Martínez, J R Chávarri Bravo, I Cuesta Esteve, Amós García Rojas, Federico M Torres, E Redondo Margüello, A Rivero Cuadrado, S Tamames Gómez, Javier Villaseca, Álvaro HIdalgo-Vega
Pathway towards an ideal and sustainable framework agreement for the public procurement of vaccines in Spain: a multi-criteria decision analysis. Human vaccines & immunotherapeutics 16 (11) (2020)
Jorge Mestre-Ferrandiz, Néboa Zozaya, Bleric Alcalá, Álvaro Hidalgo-Vega
Multi-Indication Pricing: Nice in Theory but Can it Work in Practice? PharmacoEconomics 36 (12) (2019)
Néboa Zozaya, Lucía Martínez-Galdeano, Bleric Alcalá, Jose Carlos Armario-Hita, Concepción Carmona, Y José Manuel Carrascosa, Pedro Herranz, María Jesús Lamas, Marta Trapero-Bertran, Álvaro Hidalgo-Vega
Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (3) (2018)
Rafael Busutil, Olga Espallardo, Antonio Torres, Lucía Martínez-Galdeano, Néboa Zozaya, Álvaro Hidalgo-Vega
The impact of obesity on health-related quality of life in Spain. Health and quality of life outcomes 15 (1) (2017)

Néboa Zozaya.css-eqlu8i{font-size:small;padding-left:4px;} (N Zozaya, N Zozaya González)

Publication Activity (10 Years)

Top Topics

Top Venues

Néboa Zozaya (N Zozaya, N Zozaya González)